The US Food and Drug Administration has approved a new anticoagulant for the prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery, according to the drug’s manufacturer, Janssen Pharmaceuticals Inc. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
